Sarepta Therapeutics' gene therapy for Duchenne muscular dystrophy slowed disease progression and showed sustained benefit ...
Researchers at Kumamoto University have demonstrated that iron supplementation can significantly alleviate muscle pathology and functional decline in a mouse model of facioscapulohumeral muscular ...
Muscular dystrophy is a genetic disorder that weakens muscles over time. There are many different types of muscular dystrophies. Each type begins at a different age and may cause mild or severe muscle ...
At the 44th Annual J.P. Morgan Healthcare Conference in early January 2026, Edgewise Therapeutics outlined its 2026 clinical ...
Department of Rehabilitation Medicine, Shenzhen Children’s Hospital, Shenzhen, China Objectives: This study aimed to characterize 1-year pain trajectories in children with Duchenne muscular dystrophy ...
Edgewise Therapeutics, Inc., , a leading muscle disease biopharmaceutical company, today provided updates on the Company's clinical programs and highlighted major milestones for 2026. Edgewise Chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results